choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Aegerion Pharmaceuticals IPO

Aegerion Pharmaceuticals IPO Newsletter
  • ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer 31 Mar 2016 10:04 GMT

    Aegerion Pharmaceuticals, Inc. where he was instrumental in the company's initial public offering, through which Aegerion achieved a $2 billion … Seton Hall University. About ContraVir Pharmaceuticals ContraVir is a biopharmaceutical company …

  • IPO Preview: REGENXBIO Inc. 17 Sep 2015 14:20 GMT

    … change in conclusion. The full IPO calendar is available at IPOpremium … Corporation, Avalanche Biotechnologies, Inc., BioMarin Pharmaceutical Inc., bluebird bio, Inc., Genzyme … the treatment of HoFH, including Aegerion (Juxtapid), Genzyme (Kynamro) and Amgen …

  • IPO Season Kicks Off Once More With Regenxbio 15 Sep 2015 14:17 GMT

    … $100 million in its upcoming IPO. Based in Rockville, Maryland, Regenxbio … :BLUE), BioMarin Pharmaceutical (NASDAQ:BMRN), Avalanche Biotechnologies (NASDAQ:AAVL), Aegerion (NASDAQ:AEGR … To Pre-Clinical Status After the IPO lull, investors could be ready …

  • Akcea Expands Leadership Team in Preparation for First Commercial Launch 05 Sep 2017 11:00 GMT

    … officer immediately following PureTech’s initial public offering. Previously, Mr. MacLean served as … , Ovation Pharmaceuticals, Inc., Alcon/Novartis Pharma AG and most recently Aegerion Pharmaceuticals, where … its final prospectus for its initial public offering and its most recent quarterly …

  • Mid-Afternoon Market Update: Dow Falls Over 200 Points; Catabasis Shares Spike Higher 29 Sep 2016 19:30 GMT

    … .83 billion. Equities Trading UP Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares shot … familial hypercholesterolemia. Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) got a … $14.26. Tabula Rasa priced IPO at $12 per share. Equities …

  • Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 15 Jul 2016 05:21 GMT

    … Waksal, finally unveiled IPO plans after hinting … . — Cambridge, MA-based Agios Pharmaceuticals (NASDAQ: AGIO) presented … over $1.30 apiece… Aegerion Pharmaceuticals (NASDAQ: AEGR) will … alternatives… And Infinity Pharmaceuticals (NASDAQ: INFI) and Chiasma …

  • Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 17 Jun 2016 11:34 GMT

    … Waksal, finally unveiled IPO plans after hinting … . — Cambridge, MA-based Agios Pharmaceuticals (NASDAQ: AGIO) presented … over $1.30 apiece… Aegerion Pharmaceuticals (NASDAQ: AEGR) will … alternatives… And Infinity Pharmaceuticals (NASDAQ: INFI) and Chiasma …

  • East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 11 Feb 2016 14:21 GMT

    … York —  Biotech and pharma executives from across … IPO on Thursday, despite a tough environment for biotech and even IPOs … and other diseases. —Cambridge-based Aegerion Pharmaceuticals (NASDAQ: AEGR) hired … to HT-100. —Astellas Pharma finally completed its …

  • Premarket Biotech Digest: Achaogen's Potential, KaloBios Fires Shkreli, Halozyme-Lilly Deal 22 Dec 2015 15:15 GMT

    … , Merck acquired Cubist Pharmaceuticals, which highlighted … in the prospectus. IPOs No IPOs to report. … Aegerion Pharmaceuticals (NASDAQ:AEGR) closed 15.54% higher. Agios Pharmaceuticals … Keratoconjunctivitis Sicca Mimetogen Pharmaceuticals USA, Inc.| Allergan …

Satisfied with the content?

Continue to create your account.